---
title: "GRAL.US (GRAL.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/GRAL.US/news.md"
symbol: "GRAL.US"
name: "GRAL.US"
parent: "https://longbridge.com/en/quote/GRAL.US.md"
datetime: "2026-05-20T09:06:35.147Z"
locales:
  - [en](https://longbridge.com/en/quote/GRAL.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/GRAL.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/GRAL.US/news.md)
---

# GRAL.US (GRAL.US) — Related News

### [GRAIL Says Galleri Demand Is Rising as NHS Talks, FDA Review Move Ahead](https://longbridge.com/en/news/286677381.md)
*2026-05-17T16:02:12.000Z*
> GRAIL (NASDAQ:GRAL) reports rising demand for its Galleri multi-cancer early detection test, despite recent NHS study he

### [GRAIL, Inc. $GRAL Shares Sold by Wesbanco Bank Inc.](https://longbridge.com/en/news/285931791.md)
*2026-05-11T11:19:20.000Z*
> Wesbanco Bank Inc. reduced its stake in GRAIL, Inc. (NASDAQ:GRAL) by 73% in Q4, now holding 12,000 shares after selling 

### [Here's Why Grail Shares Popped Higher This Week](https://longbridge.com/en/news/285845360.md)
*2026-05-10T15:05:22.000Z*
> Grail (NASDAQ: GRAL) shares rose 14% this week following positive first-quarter earnings and anticipation of upcoming tr

### [Here's What Analysts Are Forecasting For GRAIL, Inc. (NASDAQ:GRAL) After Its First-Quarter Results](https://longbridge.com/en/news/285738527.md)
*2026-05-08T14:00:30.000Z*
> GRAIL, Inc. (NASDAQ:GRAL) reported strong first-quarter results, with revenues of US$41m exceeding estimates by 4.2% and

### [GRAIL | 10-Q: FY2026 Q1 Revenue Beats Estimate at USD 40.79 M](https://longbridge.com/en/news/285658969.md)
*2026-05-08T03:37:55.000Z*
### [GRAIL (NASDAQ:GRAL) Shares Up 13.2% Following Earnings Beat](https://longbridge.com/en/news/285412896.md)
*2026-05-06T16:48:24.000Z*
> GRAIL, Inc. (NASDAQ:GRAL) shares surged 13.2% to $61.58 after reporting better-than-expected earnings, with EPS of ($2.2

### [](https://longbridge.com/en/news/285249887.md)
*2026-05-05T18:25:45.000Z*
> Assurant shares are trading higher after the company reported better-than-expected Q1 financial results.

### [GRAIL signals 22%-32% 2026 Galleri sales growth while starting Epic Aura integrations](https://longbridge.com/en/news/285300772.md)
*2026-05-06T02:53:18.000Z*
> GRAIL, Inc. reported strong Q1 2026 results with revenue of $40.8 million, driven by over 56,000 Galleri tests sold. The

### [Daniel Brennan Reiterates Buy on Strong Galleri Momentum, Clinical Catalysts, and Raises Price Target to $69](https://longbridge.com/en/news/285301847.md)
*2026-05-06T02:45:42.000Z*
> TD Cowen analyst Daniel Brennan has reiterated a Buy rating on GRAIL Inc, raising the price target to $69. This decision

### [GRAIL | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 40.79 M](https://longbridge.com/en/news/285258249.md)
*2026-05-05T20:12:24.000Z*